Summary & Overview
HCPCS G2096: ACE/ARB/ARNI Therapy Not Prescribed, Reason Not Given
HCPCS Level II code G2096 documents that ACE inhibitor, ARB, or ARNI therapy was not prescribed and no reason was provided. The code captures a specific documentation outcome related to cardiovascular medication decisions and is used in outpatient and ambulatory care settings to indicate absence of guideline-directed renin-angiotensin system therapy.
Nationally, recording this outcome matters for quality measurement, claims processing, and clinical record completeness because ACE inhibitors, ARBs, and ARNIs are foundational therapies for conditions such as heart failure and hypertension. Use of G2096 can influence quality reporting and payer reviews when therapy omission lacks documented rationale.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical context and intended use of the code, how it fits into outpatient medication management workflows, and what to expect in claims where no reason for withholding therapy is recorded. The publication provides benchmarks and policy-relevant interpretation where available, highlights implications for documentation and quality measurement, and summarizes administrative considerations tied to use of this HCPCS Level II code.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed payer-specific policy differences.
Billing Code Overview
HCPCS Level II code G2096 indicates that angiotensin converting enzyme (ACE) inhibitor, angiotensin receptor blocker (ARB), or angiotensin receptor-neprilysin inhibitor (ARNI) therapy was not prescribed and no reason was given. This code documents the absence of guideline-directed renin-angiotensin system therapy for a patient for whom such therapy might otherwise be considered.
-
Service type: Medication management/documentation of prescription decision
-
Typical site of service: Outpatient clinic or ambulatory care setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with diagnosed heart failure with reduced ejection fraction (HFrEF) or hypertension who is evaluated in an outpatient cardiology or primary care clinic. The clinician documents that angiotensin converting enzyme (ACE) inhibitor, angiotensin receptor blocker (ARB), or angiotensin receptor-neprilysin inhibitor (ARNI) therapy was considered but not prescribed, and no reason was recorded. The workflow begins with history and medication review, assessment of blood pressure, renal function, potassium level, and allergy history. If contraindications (for example, prior angioedema) or intolerances are present they are documented; however, when no such reason is documented, the billing code G2096 is applied to indicate ACE/ARB/ARNI therapy was not prescribed and no reason was given. Typical site of service is outpatient clinic (primary care or cardiology), and the typical patient scenario includes newly identified left ventricular systolic dysfunction or chronic heart failure follow-up where guideline-directed medical therapy would normally include an ACE, ARB, or ARNI but was not initiated or continued without documented justification.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to document or manage the decision not to prescribe is substantially greater than typical |